Parkinson's Disease

This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases

Comedian And 'Curb Your Enthusiasm' Fame Richard Lewis Dies At 76

Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment

Comedian And 'Curb Your Enthusiasm' Fame Richard Lewis Dies At 76

Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment

Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track

Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'

Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track

Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'

Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval

Elon Musk Says His Neuralink Chip Could Treat Paralysis, Stroke And Brain Injury

Parkinson's Disease Recent News

Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson's Disease

Alterity Therapeutics's (NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson's Disease.

Recent Survey Finds Many Parkinson's Disease Patients Turn To Cannabis

This article by Chynna Pearson was originally published on Cannabis & Tech Today, and appears here with permission.

Zelira Therapeutics Will Partner With The Parkinson's Foundation

FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment

Seelos Therapeutics Shares Rally Following Deal For Gene Therapy Program

Why Seelos Therapeutics Shares Are Surging Out Of The Gate

EPA Amends Proposed Regulation Of Syngenta Ingredient In Response To Public Comments

Anavex Life Sciences Jumps 28% After Promising Results From Parkinson's Trial

Goldman Initiates Impax Labs With Sell Rating, $33 Target

IBM Teams Up With Pfizer To Move Towards Parkinson's Cure

Acadia Continues Huge Rise Following FDA Panel Vote